Back to Resource Library
Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of HIV in Low- and Middle-Income Countries
![](https://www.prepwatch.org/wp-content/uploads/2022/11/barriersThumb.png)
This article from Clinical Infectious Diseases examines potential barriers to scale-up of injectable PrEP in low and middle income countries.